Silo Pharma, Inc.
corporate_fare Company Profile
Silo Pharma, Inc. (NASDAQ:SILO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for SILO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for SILO spans 8-K, 424B3, S-3, DEFA14A.
Recent high-impact activity:
- Silo Pharma Raises ~$815,000 in Private Placement Priced at $1.50
- Silo Pharma registers resale of 1.9M shares from July private placement, unlocking potential $8M cash inflow
- Silo Pharma Registers Resale of 1.9M Shares from July Private Placement, Potential $8M in Warrant Proceeds
- Silo Pharma Closes $3.5M Private Placement, Adds Resale Registration Rights
- Silo Pharma closes $4M private placement with warrants that could unlock an additional $7.7M
Financial Snapshot
Short Interest & Short Volume
1.07 days to coverFINRA reported short interest of 13,785 shares in SILO as of the October 30, 2026 settlement, a 37.6% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On November 20, 2026, 10.5% of SILO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for SILO, detected from its recent SEC filings · based on capital-structure filings through 2026-07-10.
Private Placement Closed · Warrants Add Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →